首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.
【2h】

Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.

机译:鉴定在大鼠肝脏中体内形成的主要黄曲霉毒素B1-DNA加合物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The products of in vivo covalent binding of activated aflatoxin B1 (AFB1) to DNA have been investigated in rats. The principal covalent product formed in liver DNA of rats treated with AFB1 has been identified as 2,3-dihydro-2-(N7-guanyl)-3-hydroxy-aflatoxin B1. This compound was isolated from the liver DNA of rats dosed with AFB1 (2.0 mg/kg) in sufficient quantity for characterization by physicochemical techniques, including field-desorption mass spectrometry. This information together with results of chemical methylation of the compound proved that the major adduct formed between DNA and AFB1 in vivo is identical to that produced in vitro when AFB1 is incubated with DNA in the presence of a rat liver microsomal activating system. Quantitative studies of formation of this compound revealed a dose-dependent relationship between the level of its occurence in liver DNA and AFB1 doses over the range 0.125-1.0 mg/kg.
机译:已在大鼠中研究了活化黄曲霉毒素B1(AFB1)与DNA体内共价结合的产物。经AFB1处理的大鼠肝脏DNA中形成的主要共价产物已被鉴定为2,3-二氢-2-(N7-胍基)-3-羟基-黄曲霉毒素B1。从足量注射AFB1(2.0 mg / kg)的大鼠肝脏DNA中分离出该化合物,以通过物理化学技术(包括现场解吸质谱法)进行表征。该信息以及该化合物的化学甲基化结果证明,当在大鼠肝微粒体激活系统存在下将AFB1与DNA孵育时,体内DNA与AFB1之间形成的主要加合物与体外产生的主要加合物相同。对该化合物形成的定量研究表明,其在肝脏DNA中的存在水平与AFB1剂量在0.125-1.0 mg / kg范围之间存在剂量依赖关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号